Ingevity Corporation NGVT 深 滬
等待開盤 06-25 09:30:00 美东时间
74.75
+2.090
+2.88%
華盛通- 最 高75.885
- 今 開72.89
- 成交量 22.37万股
- 最 低 72.21
- 昨 收 72.66
- 總市值 259.92万
- 52周最高 79.285
- 市盈率 靜 --
- 換手率 0.64%
- 52周最低 39.735
- 委 比 86.61%
- 總股本 3.48万
- 歷史最高 120.41
- 量 比 0.55
- 振 幅 5.06%
- 歷史最低 22.00
- 每 手 1
- 風險率 9.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ingevity Appoints Ryan Cotterman As Chief Accounting Officer
Ingevity ( ($NGVT) ) has shared an announcement. On June 22, 2026, Ingevity Cor...
今天 05:19
Dentsply Sirona appoints John Fortson as CFO
Dentsply Sirona (XRAY) on Thursday announced the appointment of John Fortson as Executive Vice President and Chief Financial Officer, effective July 20. Fortson has served for 13 years as either CFO o...
06-11 20:42
电话会总结 ｜ Ingevity(NGVT)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Ingevity业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **整体财务表现：** - 总销售收入2.58亿美元，同比增长4% - 调整后EBITDA为9200万美元，与去年同期基本持平 - 调整后EBITDA利润率为35.5%（去年同期36.8%） - 调整后每股收益1.15美元，同比增长14% - GAAP净利润2340万美元 - 调整后毛利润1.32亿美元，同比增长4%，毛利率51% - 自由现金流为负1200万美元 **分部门业绩：** - Performance Materials部门：销售收入1.55亿美元，同比增长6
06-02 12:05
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Ingevity Widens FY2026 Adj EPS Guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 Est; Lowers FY2026 Sales Guidance from $1.100B-$1.200B to $1.050B-$1.150B vs $1.187B Est
Ingevity (NYSE:NGVT) widens FY2026 Adj EPS guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 analyst estimate. Lowers FY2026 sales outlook from $1.100 billion-$1.200 billion to $1.050 billion-$1.150 billion vs $1.187
05-07 04:18
PPG Acquires Ozark Materials From Ingevity; All-Cash Transaction Includes Purchase Price Of $65M
PPG (NYSE:PPG) today announced that it has completed the acquisition of Ozark Materials, LLC, a U.S.-based provider of pavement marking solutions, from Ingevity Corporation (NYSE:NGVT). The all-cash transaction includes
04-16 04:33
BRIEF-Ingevity Corp - Enters Second Amendment And Restatement Agreement On March 26, 2026 - SEC Filing
BRIEF-Ingevity Corp - Enters Second Amendment And Restatement Agreement On March 26, 2026 - SEC Filing March 30 (Reuters) - SEC Filing: INGEVITY CORP - ENTERS SECOND AMENDMENT AND RESTATEMENT AGREEMENT ON MARCH 26, 2026 - SEC FILING INGEVITY CORP - EXTENDS MATURITY DATE OF REVOLVING CREDIT FACILITY
03-30 21:46
Ingevity cuts revolving credit facility to $750 million, extends maturity five years
Ingevity cuts revolving credit facility to $750 million, extends maturity five years Ingevity entered a second amended and restated credit agreement on March 26, 2026, refinancing its revolving credit facility. New revolver maturity extends to five years from closing date. Commitments were cut to US
03-30 18:32
Ingevity imposes temporary surcharge of USD 515/MT on Capa caprolactone products
Ingevity imposes temporary surcharge of USD 515/MT on Capa caprolactone products Ingevity announced a temporary extraordinary surcharge on its Capa caprolactone products due to increased supply chain costs. Effective immediately, the surcharge is USD 515/MT or EUR 440/MT per metric ton on all applic
03-20 21:45
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
